Global Contraceptive Pills Market Report and Forecast 2025-2034

Global Contraceptive Pills Market Outlook

The global contraceptive pills market size reached a value of USD 19.39 billion in 2024. The market is further expected to grow at a CAGR of 3.9% during the forecast period of 2025-2034, likely to attain a value of USD 27.41 billion by 2034. The growth of the market is likely to be driven by the rapid technological developments.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

North America to be Among the Significant Regional Markets for Contraceptive Pills

North America is anticipated to account for a significant share of the global contraceptive pills market in the forecast period. The region is projected to uphold its dominance throughout the forecast period, owing to the high incidence of unintended pregnancies, rise in awareness regarding contraceptive pills, the surge in adoption of modern contraceptive drugs, and an alarming increase in the prevalence of sexually transmitted diseases, such as HIV/AIDS. The United States controls a significant portion of the North American contraceptive pill market. The United States government has initiated several awareness programs about contraception and family planning, which has fuelled the industry's revenue. Several organisations are also working in the country to accomplish strategic projects. According to data published by the Bill & Melinda Gates Foundation in 2023, the foundation plans to spend USD 280 million per year from 2021 to 2030 on developing new and improved contraceptive technologies, supporting family planning programmes that reflect local community preferences, and allowing women and girls to be in control of their contraceptive care.

Due to a large population base and proactive activities by governmental organisations for birth control and awareness within developing countries, Asia Pacific is expected to increase at the fastest rate during the projected period. In addition, the availability of cost-effective contraceptive pills in this region proposes profitable opportunities for contraceptive drug manufacturers. The launch of awareness programs by government agencies and other regulatory bodies to increase the homecare usage of contraceptive pills is likely to drive the contraceptive pills market in the Asia Pacific region.

Purchase the Regional Overview for USD 1099

If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.

Purchase the Regional Overview for USD 1099

If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.

Purchase the Regional Overview for USD 1099

If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.

Purchase the Regional Overview for USD 1099

If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.

Market Segmentations

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

The contraceptive pill, also known as the birth control pill, is a kind of birth control administered orally to women. It contains an oestrogen and a progestogen combination (specifically a progestin). When used correctly, it disrupts the menstrual cycle, preventing ovulation and pregnancy.

By type, the market includes:

• Progestin-only Pills
• Combines Contraceptives Pills

The several distribution channels of the market are:

• Online Pharmacy
• Hospital Pharmacy
• Retail Pharmacy
• Public Channel and NGO
• Clinics
• Others

The regional markets for the contraceptive pills industry can be divided into North America, Europe, the Asia Pacific, Latin America, the Middle East and Africa.

Rising Awareness Among People Augmenting the Market Growth

The rising awareness among consumers about sexual health is expected to increase the demand and adoption of birth control methods, thereby augmenting the growth of contraceptive pills market. The upsurge in contraception has reduced the risk of sexually transmitted infections and enhanced health-related outcomes, comprising maternal and infant mortality. The rise in awareness of modern contraceptives, increasing use of safe and effective oral pills, and health complications related to teenage pregnancies further stimulate market expansion. Also, various government programs have increased access to contraceptives, which help prevent unwanted pregnancies in teenagers. Development, approval, and commercialisation of new, more effective, and long-acting reversible contraceptive methods are expected to drive the industry growth during the forecast period. For instance, Agile Therapeutics developed a hormonal patch, Twirla, introduced in the United States in the fourth quarter of 2020. The launch of generic and low-cost drugs and devices has led to an increase in the demand for contraceptives by teenagers. Further, the rising number of unwanted pregnancies is also one of the major factors driving the demand for contraceptive pills, thereby contributing to the market growth.

Key Players in the Global Market for Contraceptive Pills

The report gives a detailed analysis of the following key players in the global contraceptive pills market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:

• Janssen Global Services, LLC
• Pfizer Inc.
• Teva Pharmaceuticals Industry Ltd.
• Merck & Co. Inc.
• Allergan, plc
• Others

The comprehensive EMR report provides an in-depth assessment of the market based on the Porter's five forces model along with giving a SWOT analysis.

Key Highlights of the Report